MGMT and glioblastoma: Subsequently, a randomized Phase III trial (NCT00006353) in elderly GBM patients confirmed that patients with MGMT promoter methylation benefitted more from adjuvant TMZ with radiotherapy than radiotherapy alone [49], suggesting that the benefit seen in patients with MGMT promoter methylation may possibly correlated to addition of TMZ.